Use of Coraxan in Patients with Cardiac and Pulmonary Pathology

Djumaevna, Jalilova Umida

Innovative Multidisciplinary Journal of Applied Technology · 2024-yil

Annotatsiya

the article studied the effectiveness of the drug Coraxan in the complex therapy of patients with coronary heart disease (CHD) and arterial hypertension (AH) in combination with chronic obstructive pulmonary disease (COPD). The use of Coraxan in the treatment of patients with concomitant cardiopulmonary pathology leads to a significant decrease in blood pressure (BP) and heart rate (HR), and a decrease in angina attacks. Coraxan increases exercise tolerance (PE). 

Maqola ma’lumotlari
MualliflarDjumaevna, Jalilova Umida
JurnalInnovative Multidisciplinary Journal of Applied Technology
Nashr sanasi2024-05-16
Jild2
Son4
Betlar124-125
TilIngliz

Kalit so‘zlar

Coraxan, coronary heart disease, blood pressure, arterial hypertension, chronic obstructive pulmonary disease, heart rate, physical activity

Ilmiy soha

Innovative Multidisciplinary Journal of Applied Technology jurnalidan boshqa maqolalar

Innovative Multidisciplinary Journal of Applied Technology — barcha maqolalar